Here are five report insights:
1. In 2017, there were 39 drug shortages reported. In the previous two years, there were 26.
2. Although this number is much lower than 2011, when there were 251 shortages, many of the shortages that popped up “have been for critical drug products and they are having a tangible impact on patients,” the FDA reported.
3. Notable shortages in 2017 included Mylan’s EpiPen, injectable opioids and IV fluids.
4. The FDA attributed the shortages to improper manufacturing practices that caused facilities to shut down and production disruptions from hurricanes.
5. Even though there were more shortages, the FDA said it helped prevent 145.
Read the full report here.
More articles on pharmacy:
Pharmacist recommended: 30 top OTC health products of 2018
Purdue Pharma cuts remaining sales force
12 drugmakers that slashed their workforces in 2018
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.